News & Analysis on Clinical Trial Services & Contract Research And Development
The UK's chemical industry has given a cautious welcome to the government's national allocation plan (NAP) for Phase 2 of the EU Emissions Trading Scheme (ETS), warning pharma could see a rise in the price of active pharmaceutical ingredients (APIs)...
Speciality pharma company Bioprogress has launched new anti-snoring and caffeine products based on its edible film drug delivery technology, offering an effective alternative to conventional formulations.
Drug giant Merck & Co has seen flat sales and a rise in operating costs in the first quarter of 2006, as its restructuring initiative, which contract manufacturers welcomed, takes its toll on the company.
Contract manufacturer Dalton has announced the completion of its oligonucleotide (oligos) manufacturing facility, in a $500,000 (€400,000) investment drive to dominate pilot and large-scale DNA and RNA oligo synthesis.
Surface technology firm CSMA has developed the only commercially available way of seeing the differences between drug tablets of the same composition that have been manufactured by two different routes.